Policy Update – Week of July 29, 2024
Courtney Savage
August 2, 2024
No Comments
IPPS Final Rule published and seniors wait to see the product of the first Medicare drug price negotiations.
Policy Blog
Timely and informative health policy content
authored and curated by Savage Health Policy
Regulatory Update – Week of July 22, 2024
Courtney Savage
July 27, 2024
No Comments
This week – an Issue Brief on Global Surgical Payments to answer all your burning questions.
Issue Brief: Medicare Global Surgical Payments
Courtney Savage
July 26, 2024
No Comments
This issue brief addresses the topic of global payments for surgeons under the Medicare physician fee schedule (PFS): what they are, how they work (or don’t work) and why CMS seems so intent on doing away with them.
Regulatory Update – Week of July 15, 2024
Courtney Savage
July 19, 2024
No Comments
This week, Congress is out but everyone else seems to be in!
Regulatory Update – Week of July 8, 2024
Courtney Savage
July 12, 2024
No Comments
The payment rules are here!
They’re Here!
Courtney Savage
July 12, 2024
No Comments
The Fourth of July can be counted on for two things: fireworks, and Medicare payment rules, the defining documents that sort DC health policy folk into two camps. On one side, there are the Hill staffers and lobbyists who are trying to strategically plot a path through the appropriations quagmire to get to August recess. Then there are the regulatory staff whose year has just started.
Regulatory Update – Week of June 24, 2024
Courtney Savage
June 28, 2024
No Comments
This week: Becerra, Chevron, Debates, and Devices (and blood test for cancer, and obesity drug coverage)… Oh My!
Regulatory Update – Week of June 17, 2024
Courtney Savage
June 21, 2024
No Comments
This week: It’s HOT! That is all!
Regulatory Update – Week of June 10, 2024
Courtney Savage
June 14, 2024
No Comments
New MedPAC report, MA star ratings mulligan, and Congress keeps busy…
Regulatory Update – Week of June 3, 2024
Courtney Savage
June 7, 2024
1 Comment
This week features zombie cicadas, drug shortages, and some surprising placeholders being set by members of Congress who don’t plan to be around next year.
Recent Comments